Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

5 structures for P19484

Entry ID Method Resolution Chain Position Source
7UX2 EM 290 A P 1-476 PDB
7UXC EM 320 A R 1-476 PDB
7UXH EM 320 A T/j 1-476 PDB
7Y62 X-ray 200 A A/B 248-319 PDB
AF-P19484-F1 Predicted AlphaFoldDB

360 variants for P19484

Variant ID(s) Position Change Description Diseaes Association Provenance
CA138093147
rs1009313546
2 A>V No ClinGen
gnomAD
TCGA novel 3 S>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA364109584
rs1323239139
4 R>C No ClinGen
gnomAD
CA138093134
rs1053600522
4 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA364109521
rs1289665036
8 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs775220771
CA3801590
13 R>L No ClinGen
ExAC
gnomAD
COSM1444498
CA3801589
rs775220771
13 R>Q NS large_intestine Variant assessed as Somatic; 5.429e-05 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs768013768
CA3801591
COSM1672404
13 R>W haematopoietic_and_lymphoid_tissue [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA364109446
rs1414395646
16 A>T No ClinGen
gnomAD
rs769780108
CA3801588
16 A>V No ClinGen
ExAC
TOPMed
gnomAD
CA364109395
rs1175390402
18 Q>K No ClinGen
gnomAD
rs1489364755
CA364109343
20 E>G No ClinGen
gnomAD
rs1466869940
CA364109295
22 R>Q No ClinGen
gnomAD
CA364109301
rs1212743510
22 R>W No ClinGen
gnomAD
rs747182166
CA3801584
23 E>D No ClinGen
ExAC
gnomAD
CA3801583
rs758345276
24 R>C No ClinGen
ExAC
gnomAD
rs779275045
CA3801580
24 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs779275045
CA3801581
24 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA3801582
rs758345276
24 R>S No ClinGen
ExAC
gnomAD
rs912280262
CA138092972
25 M>I No ClinGen
Ensembl
rs755546119
CA3801579
25 M>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA364109222
rs1368820263
26 Q>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA364109205
rs1439083154
27 Q>K No ClinGen
gnomAD
CA364109187
rs1391152798
28 Q>* No ClinGen
TOPMed
gnomAD
TCGA novel 29 A>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1321410510
CA364109171
29 A>S No ClinGen
gnomAD
CA364109149
rs754169648
30 V>F No ClinGen
ExAC
TOPMed
gnomAD
rs754169648
CA3801577
30 V>I No ClinGen
ExAC
TOPMed
gnomAD
CA3801576
rs766777120
31 M>I No ClinGen
ExAC
gnomAD
CA364109129
rs1156920244
31 M>V No ClinGen
gnomAD
rs756491079
CA364109102
32 H>D No ClinGen
ExAC
gnomAD
rs751129305
CA3801574
32 H>R No ClinGen
ExAC
TOPMed
gnomAD
rs756491079
CA3801575
32 H>Y Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs762308294
CA3801572
34 M>L No ClinGen
ExAC
gnomAD
CA364108998
rs1362836940
35 Q>E No ClinGen
TOPMed
CA138092924
rs930729175
38 Q>K No ClinGen
TOPMed
CA3801571
rs150746914
40 Q>H No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1258425442
CA364108836
41 Q>R No ClinGen
gnomAD
rs1396065578
CA364108803
42 Q>L No ClinGen
gnomAD
CA138092911
rs920105606
45 L>I No ClinGen
gnomAD
rs1232586578
CA364108686
46 G>E No ClinGen
gnomAD
CA3801562
rs776735262
46 G>R No ClinGen
ExAC
TOPMed
gnomAD
CA364108661
rs1367767356
47 G>E No ClinGen
gnomAD
rs112978677
CA3801561
48 P>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 49 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs773250890
CA3801559
50 T>A No ClinGen
ExAC
gnomAD
rs773250890
CA364108612
50 T>P No ClinGen
ExAC
gnomAD
rs199806477
CA3801558
51 P>L No ClinGen
1000Genomes
ExAC
gnomAD
rs1020301102
CA138092877
52 A>T No ClinGen
TOPMed
gnomAD
CA364108517
rs1172878311
55 T>A No ClinGen
gnomAD
CA138092876
rs989657892
55 T>N No ClinGen
TOPMed
CA364108515
rs1172878311
55 T>P No ClinGen
gnomAD
rs749744873
CA364108497
56 P>L No ClinGen
ExAC
gnomAD
rs749744873
CA3801554
56 P>R No ClinGen
ExAC
gnomAD
rs750809443
CA3801551
57 V>A No ClinGen
ExAC
TOPMed
gnomAD
rs756401217
CA364108492
57 V>F No ClinGen
ExAC
TOPMed
gnomAD
rs756401217
CA3801552
57 V>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs756401217
CA138092823
57 V>L No ClinGen
ExAC
TOPMed
gnomAD
CA3801550
rs763636856
61 S>L No ClinGen
ExAC
TOPMed
gnomAD
rs999187566
CA364108394
63 P>L No ClinGen
TOPMed
gnomAD
rs999187566
CA138092806
63 P>R No ClinGen
TOPMed
gnomAD
CA3801548
rs752129807
64 P>L No ClinGen
ExAC
gnomAD
CA138092798
rs752664763
64 P>S No ClinGen
TOPMed
rs1581879621
CA364108303
69 V>E No ClinGen
Ensembl
CA138092627
rs1048213228
76 L>R No ClinGen
TOPMed
CA364108000
rs1169506393
82 Y>C No ClinGen
TOPMed
CA364107985
rs1291494004
83 H>Y No ClinGen
gnomAD
CA364107963
rs1561851683
84 L>V No ClinGen
Ensembl
CA3801530
rs778715283
90 Q>H No ClinGen
ExAC
gnomAD
CA364107797
rs1428060360
91 K>R No ClinGen
Ensembl
rs1394029477
CA364107781
92 V>L No ClinGen
gnomAD
CA3801526
rs760706046
93 R>L No ClinGen
ExAC
TOPMed
gnomAD
CA3801527
rs760706046
93 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA3801528
rs374238733
93 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1581879141
CA364107700
95 Y>* No ClinGen
Ensembl
rs781007634
CA138092554
97 S>A No ClinGen
Ensembl
CA364107650
rs1473263334
98 E>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA364107654
rs1473263334
98 E>Q No ClinGen
TOPMed
gnomAD
CA364107596
rs1364901947
100 Y>C No ClinGen
TOPMed
gnomAD
rs768875430
CA3801521
102 N>K No ClinGen
ExAC
gnomAD
rs1346699769
CA364107547
102 N>S No ClinGen
TOPMed
CA364107554
rs1277822981
102 N>Y No ClinGen
TOPMed
CA364107494
rs890814726
104 F>C No ClinGen
gnomAD
CA138092530
rs890814726
104 F>S No ClinGen
gnomAD
rs1215893543
CA364107484
105 A>T No ClinGen
TOPMed
CA3801520
rs370824879
106 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA364107450
rs1271467021
106 A>V No ClinGen
gnomAD
rs940663147
CA138092478
110 P>S No ClinGen
TOPMed
gnomAD
rs746340602
CA3801517
111 A>D No ClinGen
ExAC
TOPMed
gnomAD
CA3801518
rs770182531
111 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs564579264
CA3801516
112 Q>P No ClinGen
1000Genomes
ExAC
gnomAD
rs1430440554
CA364107349
113 G>D No ClinGen
gnomAD
CA3801515
rs771263853
114 S>C No ClinGen
ExAC
gnomAD
CA3801513
rs746642722
115 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA3801514
rs544888820
115 P>S No ClinGen
1000Genomes
ExAC
gnomAD
CA364107273
rs1581878810
116 K>N No ClinGen
Ensembl
rs753367483
CA3801511
117 P>L No ClinGen
ExAC
gnomAD
CA364107226
rs1417381607
119 P>S No ClinGen
gnomAD
rs138679180
CA364107196
121 A>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs138679180
CA3801509
121 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs867320791
CA138092392
123 P>L No ClinGen
Ensembl
CA364107136
rs1434277850
124 G>R No ClinGen
TOPMed
rs750334320
CA3801508
125 V>A No ClinGen
ExAC
TOPMed
rs750334320
CA364107113
125 V>E No ClinGen
ExAC
TOPMed
CA3801507
rs746778219
126 R>Q No ClinGen
ExAC
gnomAD
rs751410442
CA3801505
127 A>D No ClinGen
ExAC
CA3801506
rs761608824
127 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs764292602
CA3801504
129 H>R No ClinGen
ExAC
gnomAD
rs75455499
CA138092350
130 V>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs75455499
CA3801502
130 V>M No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs769882166
CA3801501
131 L>R No ClinGen
ExAC
gnomAD
CA3801498
rs747374333
135 A>S No ClinGen
ExAC
TOPMed
gnomAD
CA3801497
rs747374333
135 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1273804383
CA364106890
137 N>D No ClinGen
TOPMed
rs1469708651
CA364106884
137 N>S No ClinGen
TOPMed
CA3801493
rs768400942
141 N>S No ClinGen
ExAC
gnomAD
CA3801494
rs768400942
141 N>T No ClinGen
ExAC
gnomAD
rs140986611
CA3801492
148 H>R No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs779602633
CA3801491
151 S>C No ClinGen
ExAC
TOPMed
gnomAD
rs370256165
CA3801490
155 R>T No ClinGen
ESP
ExAC
gnomAD
rs374091927
CA3801471
157 L>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1433434596
CA364104597
159 D>V No ClinGen
TOPMed
rs780602753
CA3801470
162 D>V No ClinGen
ExAC
gnomAD
rs1188640179
CA364104524
163 N>D No ClinGen
gnomAD
CA3801469
rs562329587
165 M>V No ClinGen
1000Genomes
ExAC
gnomAD
CA364104454
rs369743790
166 R>C Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA3801468
rs369743790
166 R>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3801467
rs376705826
166 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA364104413
rs146588109
168 D>E No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 168 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA364104407
rs1311125282
COSM188238
169 D>N large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
CA3801465
rs752495595
170 V>A No ClinGen
ExAC
gnomAD
TCGA novel 170 V>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA364104349
rs1336389507
171 L>P No ClinGen
gnomAD
rs765494413
CA3801464
172 G>D No ClinGen
ExAC
TOPMed
gnomAD
CA364104238
rs1463483509
175 N>S No ClinGen
TOPMed
rs1262423668
CA364104252
175 N>Y No ClinGen
TOPMed
rs373670508
CA138091168
178 M>I No ClinGen
Ensembl
CA364104114
rs1232083162
179 Q>H No ClinGen
gnomAD
rs1354151368
CA364104083
180 M>I No ClinGen
gnomAD
CA138091131
rs932375573
183 T>M No ClinGen
TOPMed
gnomAD
rs755195756
CA3801463
183 T>S No ClinGen
ExAC
gnomAD
CA3801437
rs764312703
185 P>A No ClinGen
ExAC
gnomAD
CA3801436
rs764312703
185 P>T No ClinGen
ExAC
gnomAD
TCGA novel 188 S>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3801435
rs763384049
189 S>G No ClinGen
ExAC
TOPMed
gnomAD
rs890308456
CA138089780
193 V>M No ClinGen
TOPMed
rs909431482
CA138089775
194 Y>C No ClinGen
Ensembl
CA364102615
rs1177769583
195 S>G No ClinGen
gnomAD
rs76998171
CA3801433
195 S>N No ClinGen
1000Genomes
ExAC
TOPMed
CA3801432
rs760177344
196 S>N No ClinGen
ExAC
gnomAD
rs747987166
CA3801429
197 D>A No ClinGen
ExAC
gnomAD
rs948054939
CA138089722
197 D>E No ClinGen
TOPMed
gnomAD
CA3801430
rs771976205
197 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA3801428
rs778939845
198 P>A No ClinGen
ExAC
gnomAD
rs367958829
CA3801427
198 P>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs778939845
CA364102522
198 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs916548197
CA138089696
199 Q>H No ClinGen
gnomAD
rs1400378753
CA364102478
199 Q>P No ClinGen
TOPMed
TCGA novel 199 Q>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs780408177
CA3801425
200 V>I No ClinGen
ExAC
gnomAD
CA364102425
rs1395450019
201 T>A No ClinGen
gnomAD
CA364102396
rs1249153367
202 A>T No ClinGen
gnomAD
TCGA novel 206 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3801423
rs374124410
207 V>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs757376682
CA138089655
210 S>N No ClinGen
ExAC
gnomAD
rs757376682
CA3801421
210 S>T No ClinGen
ExAC
gnomAD
CA3801419
rs370711905
214 A>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs370711905
CA3801420
214 A>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs868112818
CA138089597
215 D>N No ClinGen
Ensembl
rs1231438633
CA364101810
217 T>N No ClinGen
gnomAD
CA364101799
rs1309522121
218 Q>* No ClinGen
gnomAD
CA364101766
rs1296508913
220 R>G No ClinGen
gnomAD
CA3801416
rs765986780
220 R>L No ClinGen
ExAC
TOPMed
gnomAD
rs765986780
CA3801417
220 R>P No ClinGen
ExAC
TOPMed
gnomAD
rs202212685
CA3801388
226 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3801387
rs201131499
227 S>N No ClinGen
ExAC
TOPMed
gnomAD
CA364101411
rs1242504063
228 R>S No ClinGen
gnomAD
rs1283565397
CA364101427
228 R>T No ClinGen
gnomAD
CA364101379
rs1337401046
229 A>D No ClinGen
gnomAD
rs1561849014
CA364101346
231 A>T No ClinGen
Ensembl
rs745674792
CA364101287
233 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1285660720
CA364101295
233 E>G No ClinGen
TOPMed
rs1445719642
CA364101307
233 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1327480600
CA364101262
234 R>W No ClinGen
TOPMed
gnomAD
CA364101227
rs1461547993
235 Q>R No ClinGen
gnomAD
CA3801385
rs776983107
239 N>S No ClinGen
ExAC
gnomAD
CA138089049
rs267601030
244 E>K No ClinGen
Ensembl
COSM188235
CA364100692
rs1323946945
247 R>* large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA3801353
rs757971193
249 F>Y No ClinGen
ExAC
gnomAD
TCGA novel 250 N>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1298190231
CA364100576
251 I>L No ClinGen
gnomAD
COSM3411100
rs1561848484
CA364100438
254 R>C Variant assessed as Somatic; impact. central_nervous_system [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
Ensembl
NCI-TCGA
rs369055043
CA3801351
259 G>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1414215408
CA364100223
260 M>I No ClinGen
gnomAD
rs1174695475
CA364100241
260 M>V No ClinGen
gnomAD
rs111941202
CA138089033
262 I>V No ClinGen
gnomAD
rs759599553
CA3801350
266 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA138089011
rs761666378
267 D>G No ClinGen
Ensembl
CA364099962
rs1475823563
268 L>P No ClinGen
gnomAD
rs1281647905
CA364098443
269 D>H No ClinGen
gnomAD
rs762070252
CA3801324
270 V>M No ClinGen
ExAC
TOPMed
gnomAD
CA364098342
rs1463113136
271 R>C No ClinGen
gnomAD
rs1395304773
CA364098326
271 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs1165467802
CA364098280
272 W>L No ClinGen
gnomAD
CA364098129
rs1411484013
276 T>I No ClinGen
gnomAD
CA138088214
rs778301600
288 M>I No ClinGen
TOPMed
gnomAD
rs764114762
CA364097820
290 K>N No ClinGen
ExAC
TOPMed
gnomAD
CA364097804
rs1176395140
291 D>G No ClinGen
gnomAD
CA364097777
rs1469468774
292 L>V No ClinGen
gnomAD
rs762944057
CA3801321
293 Q>R No ClinGen
ExAC
TOPMed
rs1265530890
CA364097728
294 K>T No ClinGen
TOPMed
gnomAD
CA138088196
rs901217074
296 R>T No ClinGen
Ensembl
CA3801320
rs776003877
302 S>A No ClinGen
ExAC
TOPMed
gnomAD
CA138088184
rs779208482
303 R>C No ClinGen
TOPMed
gnomAD
CA3801319
rs770274294
303 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs144086780
CA3801317
304 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs771448522
CA3801316
COSM1292321
304 R>H haematopoietic_and_lymphoid_tissue [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs771448522
CA364097473
304 R>L No ClinGen
ExAC
gnomAD
rs1406716158
CA364097392
CA364097404
307 M>L No ClinGen
TOPMed
CA138088157
rs901553385
310 K>M No ClinGen
TOPMed
rs778713362
CA3801313
313 W>R No ClinGen
ExAC
gnomAD
CA3801311
rs748808677
315 R>C Variant assessed as Somatic; 4.62e-05 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA3801310
rs371625604
315 R>H No ClinGen
ESP
ExAC
gnomAD
rs1237023857
CA364097070
317 Q>* No ClinGen
TOPMed
CA364097033
rs1561847710
317 Q>R No ClinGen
Ensembl
rs1345982768
CA364096530
320 E>D No ClinGen
TOPMed
rs1431016061
CA364096409
324 R>* No ClinGen
gnomAD
rs202215923
CA3801294
324 R>Q No ClinGen
1000Genomes
ExAC
gnomAD
rs1193680037
CA364096370
325 V>M No ClinGen
gnomAD
rs768261155
CA3801292
327 G>S No ClinGen
ExAC
gnomAD
rs1303746066
CA364096282
327 G>V No ClinGen
TOPMed
COSM3782067
rs748799545
CA3801291
329 P>S pancreas [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA364096182
rs1327037506
331 T>I No ClinGen
gnomAD
rs1581866892
CA364096199
331 T>P No ClinGen
Ensembl
TCGA novel 332 S>F Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
COSM1229048
CA3801290
rs779478102
333 P>L large_intestine [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA364096088
rs1276196091
335 G>D No ClinGen
gnomAD
rs781108610
CA3801287
335 G>S No ClinGen
ExAC
gnomAD
CA3801286
rs567571109
336 M>R No ClinGen
ExAC
TOPMed
gnomAD
CA138087324
rs567571109
336 M>T No ClinGen
ExAC
TOPMed
gnomAD
CA3801285
rs751412099
342 A>S No ClinGen
ExAC
TOPMed
gnomAD
rs866984388
CA138087311
343 Q>H No ClinGen
TOPMed
gnomAD
CA364095724
rs1182009836
345 V>M No ClinGen
TOPMed
rs868060082
CA138087271
346 V>L No ClinGen
Ensembl
CA364095658
rs1477181026
348 Q>E No ClinGen
TOPMed
gnomAD
CA138087247
rs867074696
348 Q>H No ClinGen
Ensembl
CA364095634
rs1171621513
349 E>Q No ClinGen
gnomAD
CA138087243
rs758600931
CA364095514
352 S>R No ClinGen
ExAC
TOPMed
gnomAD
rs369557141
CA3801282
353 E>* No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs369557141
CA3801281
353 E>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
TCGA novel 354 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA138087211
rs547336694
356 P>Q No ClinGen
Ensembl
CA138087194
rs936413114
357 G>E No ClinGen
TOPMed
gnomAD
CA3801280
rs759665669
357 G>W No ClinGen
ExAC
gnomAD
CA3801279
rs754340609
359 A>V No ClinGen
ExAC
gnomAD
rs1366588408
CA364095272
361 M>L No ClinGen
TOPMed
TCGA novel 362 L>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA364095202
rs1316107258
363 G>E No ClinGen
TOPMed
gnomAD
CA138087165
rs764174709
364 A>D No ClinGen
Ensembl
rs761119145
CA3801277
364 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs944195458
CA138087152
366 V>A No ClinGen
TOPMed
gnomAD
rs773749768
CA3801276
366 V>I No ClinGen
ExAC
gnomAD
CA3801275
rs768331806
368 D>H No ClinGen
ExAC
TOPMed
gnomAD
rs912791145
CA138087149
370 E>K No ClinGen
Ensembl
CA364094949
rs1397486669
371 P>L No ClinGen
gnomAD
rs762463547
CA3801274
372 L>M No ClinGen
ExAC
TOPMed
gnomAD
CA364094938
rs1458873873
372 L>P No ClinGen
gnomAD
CA3801273
rs775238854
374 A>P No ClinGen
ExAC
gnomAD
rs930265945
CA138087113
375 L>P No ClinGen
Ensembl
rs745391817
CA3801271
376 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs769115164
CA3801272
376 P>S No ClinGen
ExAC
gnomAD
CA3801269
rs371923346
377 P>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA364094808
rs1357002894
378 Q>* No ClinGen
gnomAD
CA364094795
rs1242401930
378 Q>H No ClinGen
TOPMed
gnomAD
rs1264743239
CA364094803
378 Q>R No ClinGen
gnomAD
rs1355580154
CA364094778
379 A>V No ClinGen
gnomAD
CA3801267
rs199923357
380 P>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA364094739
rs1374118771
381 L>P No ClinGen
gnomAD
TCGA novel 382 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs200813055
CA3801265
382 P>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs1386801729
CA364094735
382 P>T No ClinGen
gnomAD
rs958777837
CA138087049
383 L>M No ClinGen
gnomAD
CA364094693
rs1381296377
384 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA3801263
rs367953835
385 T>I No ClinGen
ExAC
gnomAD
rs1581866195
CA364094675
385 T>P No ClinGen
Ensembl
CA3801261
rs766963551
388 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA3801262
rs529500196
388 P>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
TCGA novel 390 P>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA364094514
rs1451086472
392 H>R No ClinGen
TOPMed
gnomAD
rs1207976107
CA364094488
393 H>P No ClinGen
gnomAD
rs1024834290
CA138087010
393 H>Y No ClinGen
TOPMed
gnomAD
CA138086997
rs1009886529
394 L>P No ClinGen
Ensembl
rs1239113356
CA364094369
398 H>Y No ClinGen
gnomAD
CA364094313
rs1233394725
401 S>G No ClinGen
gnomAD
CA3801258
rs61756225
401 S>N No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA364094241
rs1230529997
404 G>D No ClinGen
TOPMed
CA3801257
rs762238012
404 G>S No ClinGen
ExAC
gnomAD
CA364094235
rs1294083758
405 R>K Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs774944667
CA3801256
407 D>G No ClinGen
ExAC
rs1361655992
CA364094222
407 D>N No ClinGen
gnomAD
CA3801254
rs148691652
408 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs200419657
CA364094144
410 P>A No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs200419657
CA3801252
410 P>T No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA138086984
rs767286999
411 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA3801250
rs767286999
411 P>R No ClinGen
ExAC
TOPMed
gnomAD
CA3801251
rs200070041
411 P>S No ClinGen
ExAC
gnomAD
rs1169110709
CA364094061
412 G>D No ClinGen
gnomAD
CA3801248
rs748034892
412 G>R No ClinGen
ExAC
gnomAD
rs1263752675
CA364093997
414 P>L No ClinGen
gnomAD
rs749355801
CA3801245
415 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA364093941
rs1280376075
416 P>S No ClinGen
gnomAD
CA3801243
rs756293100
417 L>V No ClinGen
ExAC
gnomAD
rs750828378
CA364093904
418 A>E No ClinGen
ExAC
TOPMed
gnomAD
COSM1079233
CA3801242
rs750828378
418 A>V Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs757546185
COSM339204
CA3801240
419 P>L lung [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA364093824
rs764763608
CA3801238
420 G>R No ClinGen
ExAC
gnomAD
rs776300374
CA3801236
421 H>Y No ClinGen
ExAC
gnomAD
CA3801234
rs760195807
424 P>A No ClinGen
ExAC
gnomAD
TCGA novel 424 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs201604256
CA3801233
425 F>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA364093681
rs1478178081
426 P>L No ClinGen
gnomAD
rs772114655
CA3801232
427 S>T No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 429 S>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1238997128
CA364093646
430 K>E No ClinGen
gnomAD
rs1441515853
CA364093589
432 D>E No ClinGen
gnomAD
rs1052269027
CA138086869
432 D>Y No ClinGen
TOPMed
CA364093543
rs1317959655
436 M>T No ClinGen
gnomAD
rs1200035703
CA364093550
436 M>V No ClinGen
gnomAD
rs1258054412
CA364093521
438 L>P No ClinGen
gnomAD
CA364093505
rs149888805
439 D>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs981508062
CA138086846
440 D>N No ClinGen
gnomAD
CA3801228
rs749480529
444 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs1447698474
CA364093455
444 P>S No ClinGen
gnomAD
TCGA novel 449 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3801227
rs780428161
450 L>F No ClinGen
ExAC
gnomAD
CA364093324
rs1581865394
452 S>P No ClinGen
Ensembl
rs1168548008
CA364093293
453 T>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA3801224
rs781543713
454 M>L No ClinGen
ExAC
gnomAD
rs781543713
CA3801225
454 M>V No ClinGen
ExAC
gnomAD
CA3801223
rs757820612
455 S>F No ClinGen
ExAC
gnomAD
rs1040783093
CA138086780
456 P>L No ClinGen
TOPMed
rs200747432
CA3801220
457 E>K No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1240931901
CA364093188
458 A>D No ClinGen
TOPMed
gnomAD
rs753435246
CA3801219
462 S>I No ClinGen
ExAC
gnomAD
CA364093058
rs1236877222
463 S>R No ClinGen
TOPMed
rs369809425
CA3801218
464 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3801217
rs758123474
464 R>H No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 465 R>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs772819310
CA3801216
465 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA3801215
rs767336673
466 S>N No ClinGen
ExAC
TOPMed
gnomAD
rs111268347
CA138086712
469 S>I No ClinGen
Ensembl
CA138086711
rs112562920
470 M>V No ClinGen
Ensembl
CA364092768
rs1376346178
472 E>K No ClinGen
gnomAD
CA3801213
rs376769581
473 G>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1338998836
CA364092710
474 D>A No ClinGen
TOPMed
rs749108653
CA364092722
474 D>N No ClinGen
ExAC
TOPMed
CA3801211
rs749108653
474 D>Y No ClinGen
ExAC
TOPMed
rs1165355047
CA364092690
475 V>E No ClinGen
TOPMed
gnomAD
rs1165355047
CA364092688
475 V>G No ClinGen
TOPMed
gnomAD

No associated diseases with P19484

4 regional properties for P19484

Type Name Position InterPro Accession
domain Myc-type, basic helix-loop-helix (bHLH) domain 235 - 294 IPR011598
domain MiT/TFE transcription factors, C-terminal 321 - 473 IPR021802
domain Transcription factor EB, bHLHzip domain 226 - 316 IPR024098
domain MiT/TFE transcription factors, N-terminal 4 - 162 IPR031867

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
  • Cytoplasm, cytosol
  • Lysosome membrane
  • Mainly present in the cytoplasm (PubMed:23434374, PubMed:33691586, PubMed:35662396)
  • When nutrients are present, recruited to the lysosomal membrane via association with GDP-bound RagC/RRAGC (or RagD/RRAGD): it is then phosphorylated by MTOR (PubMed:23401004, PubMed:32612235, PubMed:36697823)
  • Phosphorylation by MTOR prevents nuclear translocation and activity by promoting interaction with 14-3-3 proteins, such as YWHAZ (PubMed:22343943, PubMed:22692423, PubMed:23401004, PubMed:25720963, PubMed:32612235, PubMed:32753672, PubMed:35662396, PubMed:36697823, PubMed:37079666)
  • Under aberrant lysosomal storage conditions, it translocates from the cytoplasm to the nucleus (PubMed:21617040, PubMed:22576015, PubMed:23434374, PubMed:25720963, PubMed:32753672)
  • The translocation to the nucleus is regulated by ATP13A2 (PubMed:23434374, PubMed:27278822)
  • Conversely, inhibition of mTORC1, starvation and lysosomal disruption, promotes dephosphorylation and translocation to the nucleus (PubMed:22343943, PubMed:22692423, PubMed:37079666)
  • Exported from the nucleus in response to nutrient availability (PubMed:30120233)
  • In macrophages, translocates into the nucleus upon live S
  • enterica infection (PubMed:27184844)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
chromatin The ordered and organized complex of DNA, protein, and sometimes RNA, that forms the chromosome.
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
cytosol The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
lysosomal membrane The lipid bilayer surrounding the lysosome and separating its contents from the cell cytoplasm.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

7 GO annotations of molecular function

Name Definition
DNA-binding transcription factor activity A transcription regulator activity that modulates transcription of gene sets via selective and non-covalent binding to a specific double-stranded genomic DNA sequence (sometimes referred to as a motif) within a cis-regulatory region. Regulatory regions include promoters (proximal and distal) and enhancers. Genes are transcriptional units, and include bacterial operons.
DNA-binding transcription factor activity, RNA polymerase II-specific A DNA-binding transcription factor activity that modulates the transcription of specific gene sets transcribed by RNA polymerase II.
enzyme binding Binding to an enzyme, a protein with catalytic activity.
protein dimerization activity The formation of a protein dimer, a macromolecular structure consists of two noncovalently associated identical or nonidentical subunits.
RNA polymerase II cis-regulatory region sequence-specific DNA binding Binding to a specific upstream regulatory DNA sequence (transcription factor recognition sequence or binding site) located in cis relative to the transcription start site (i.e., on the same strand of DNA) of a gene transcribed by RNA polymerase II.
sequence-specific double-stranded DNA binding Binding to double-stranded DNA of a specific nucleotide composition, e.g. GC-rich DNA binding, or with a specific sequence motif or type of DNA, e.g. promotor binding or rDNA binding.
transcription cis-regulatory region binding Binding to a specific sequence of DNA that is part of a regulatory region that controls transcription of that section of the DNA. The transcribed region might be described as a gene, cistron, or operon.

15 GO annotations of biological process

Name Definition
adaptive immune response An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
antibacterial innate immune response An defense response against a bacteria mediated through an innate immune response. An innate immune response is mediated by germline encoded components that directly recognize components of potential pathogens.
autophagy The cellular catabolic process in which cells digest parts of their own cytoplasm; allows for both recycling of macromolecular constituents under conditions of cellular stress and remodeling the intracellular structure for cell differentiation.
cellular response to amino acid starvation Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of amino acids.
cellular response to starvation Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of deprivation of nourishment.
embryonic placenta development The embryonically driven process whose specific outcome is the progression of the placenta over time, from its formation to the mature structure. The placenta is an organ of metabolic interchange between fetus and mother, partly of embryonic origin and partly of maternal origin.
humoral immune response An immune response mediated through a body fluid.
lysosome localization Any process in which a lysosome is transported to, and/or maintained in, a specific location.
lysosome organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a lysosome. A lysosome is a cytoplasmic, membrane-bounded organelle that is found in most animal cells and that contains a variety of hydrolases.
positive regulation of autophagy Any process that activates, maintains or increases the rate of autophagy. Autophagy is the process in which cells digest parts of their own cytoplasm.
positive regulation of DNA-templated transcription Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
positive regulation of transcription by RNA polymerase II Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
regulation of DNA-templated transcription Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
regulation of gene expression Any process that modulates the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA).
regulation of transcription by RNA polymerase II Any process that modulates the frequency, rate or extent of transcription mediated by RNA polymerase II.

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q15853 USF2 Upstream stimulatory factor 2 Homo sapiens (Human) PR
Q08874 Mitf Microphthalmia-associated transcription factor Mus musculus (Mouse) PR
Q9R210 Tfeb Transcription factor EB Mus musculus (Mouse) PR
Q8S3F1 NAI1 Transcription factor NAI1 Arabidopsis thaliana (Mouse-ear cress) PR
10 20 30 40 50 60
MASRIGLRMQ LMREQAQQEE QRERMQQQAV MHYMQQQQQQ QQQQLGGPPT PAINTPVHFQ
70 80 90 100 110 120
SPPPVPGEVL KVQSYLENPT SYHLQQSQHQ KVREYLSETY GNKFAAHISP AQGSPKPPPA
130 140 150 160 170 180
ASPGVRAGHV LSSSAGNSAP NSPMAMLHIG SNPERELDDV IDNIMRLDDV LGYINPEMQM
190 200 210 220 230 240
PNTLPLSSSH LNVYSSDPQV TASLVGVTSS SCPADLTQKR ELTDAESRAL AKERQKKDNH
250 260 270 280 290 300
NLIERRRRFN INDRIKELGM LIPKANDLDV RWNKGTILKA SVDYIRRMQK DLQKSRELEN
310 320 330 340 350 360
HSRRLEMTNK QLWLRIQELE MQARVHGLPT TSPSGMNMAE LAQQVVKQEL PSEEGPGEAL
370 380 390 400 410 420
MLGAEVPDPE PLPALPPQAP LPLPTQPPSP FHHLDFSHSL SFGGREDEGP PGYPEPLAPG
430 440 450 460 470
HGSPFPSLSK KDLDLMLLDD SLLPLASDPL LSTMSPEASK ASSRRSSFSM EEGDVL